Translating In Vitro Antiviral Activity to the In Vivo Setting: A Crucial Step in Fighting COVID-19 | FDA

Translating In Vitro Antiviral Activity to the In Vivo Setting: A Crucial Step in Fighting COVID-19 | FDA

Spotlight on CDER Science - Translating In Vitro Antiviral Activity to the In Vivo Setting: A Crucial Step in Fighting COVID-19

Preliminary data that indicate whether drug products might be effective against the virus that causes COVID-19 may come from studies of cultured cells infected in the laboratory. The successful and safe translation of cell culture data to the fight against COVID-19 will require a rigorous understanding of antiviral activities identified in cell cultures.

Learn More